Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nephros (NEPH) Other Accumulated Expenses (2016 - 2024)

Historic Other Accumulated Expenses for Nephros (NEPH) over the last 15 years, with Q4 2024 value amounting to $53000.0.

  • Nephros' Other Accumulated Expenses fell 4361.7% to $53000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $53000.0, marking a year-over-year decrease of 4361.7%. This contributed to the annual value of $53000.0 for FY2024, which is 4361.7% down from last year.
  • As of Q4 2024, Nephros' Other Accumulated Expenses stood at $53000.0, which was down 4361.7% from $94000.0 recorded in Q4 2023.
  • Nephros' Other Accumulated Expenses' 5-year high stood at $94000.0 during Q4 2021, with a 5-year trough of $26000.0 in Q4 2022.
  • In the last 5 years, Nephros' Other Accumulated Expenses had a median value of $67000.0 in 2020 and averaged $66800.0.
  • As far as peak fluctuations go, Nephros' Other Accumulated Expenses crashed by 7234.04% in 2022, and later surged by 26153.85% in 2023.
  • Over the past 5 years, Nephros' Other Accumulated Expenses (Quarter) stood at $67000.0 in 2020, then soared by 40.3% to $94000.0 in 2021, then plummeted by 72.34% to $26000.0 in 2022, then skyrocketed by 261.54% to $94000.0 in 2023, then crashed by 43.62% to $53000.0 in 2024.
  • Its Other Accumulated Expenses was $53000.0 in Q4 2024, compared to $94000.0 in Q4 2023 and $26000.0 in Q4 2022.